SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels post-results selloff centers on a weaker-than-expected outlook, with traders pointing to persistent PC weakness and manufacturing constraints despite stronger areas of the quarterly report. The community is split between calling the decline an overreaction and buying the dip, and seeing the guidance as a sign of prolonged weakness and further downside.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is selling off despite a strong quarterly report, raised guidance and an announced 8-for-1 split, amid a broader tech and chip-sector decline after a sharp rally. Traders debate whether the drop is profit-taking and sector pressure or a warning that memory pricing may be peaking; bullish traders argue demand and results remain strong.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

A reported major Binance security breach and temporary suspension of deposits and withdrawals have weighed on Bitcoin, renewing concerns about exchange security and crypto-market confidence. Traders disagree on whether the selloff signals deeper downside or a buying opportunity, with some emphasizing that the incident involved an exchange rather than Bitcoins network and noting Bitcoins relative resilience.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons quarterly results and outlook have drawn attention as investors weigh heavy AI and data-center spending, negative free cash flow, and modest revenue and earnings misses against accelerating AWS growth. The selloff has prompted debate between traders concerned that spending may outpace returns and those viewing the cloud growth and infrastructure demand as a long-term positive.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A tech-led selloff following Amazon and Intel results has intensified concerns that heavy AI spending may not deliver adequate returns, weighing on the Nasdaq-100. Traders debate whether this signals a broader AI-trade unwind or an overdone pullback, with some viewing the decline as a buying opportunity.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians quarterly results beat expectations and the company raised its delivery outlook, citing demand for the R2; traders also welcomed its reaffirmed Volkswagen partnership. The reaction is broadly upbeat, but some remain concerned about cash burn and profitability, while others say the shares have not responded strongly enough to the results.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples relative strength as other technology and AI-linked stocks sell off is driving discussion, with traders describing it as a safe-haven or anti-AI rotation that is helping support broader indexes. Bulls view its lower AI spending and established business as defensive, while bears argue the valuation is stretched and question whether earnings, product demand, and iPhone Duo screen complaints can justify the share price.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddits post-earnings selloff is centered on below-expectation Q4 guidance, weaker-than-expected user growth and declining Google search referrals, alongside plans to test a logged-in-only experience. Traders worry AI-driven search changes and a login wall could further reduce traffic, while others view the drop as an overreaction to an otherwise strong quarter.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

Binances reported multibillion-dollar security breach is driving attention, with traders focused on suspended withdrawals, frozen assets and possible spillover into BNB and broader crypto markets. Many express concern about exchange safety and trust, while others argue Binance can cover losses and question how much the incident will affect customer funds.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Weak Amazon and Intel results have intensified a tech-led pullback, with traders questioning whether heavy AI spending will deliver adequate returns; elevated oil prices and Iran-related concerns add to risk-off worries. The community is split between expecting further declines and treating the selloff as a buying opportunity or rebound setup.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETFs That You May Consider Amid a Strengthening Biotech Outlook

Drug innovation, AI and rising M&A activity are boosting biotech optimism. Discover ETFs offering exposure to the sector.

BNTX Stock Selloff Deepens Doubts: BMO Ties BNT113 Miss To Wider mRNA Cancer Vaccine Struggles

Equity

BMO Capital Markets analyst Evan David Seigerman said that the PFS miss for BNT113 “adds to a growing list of recent mRNA cancer vaccine setbacks” and is likely to pressure the stock. 


Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate 

Biotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP

Biotech ETFs are riding innovation, obesity drug growth and M&A, offering diversified exposure to the sector???s powerful rally.

Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth 

 Biotech ETFs are riding a powerful rally fueled by innovation, obesity drugs and M&A, with three funds offering diversified exposure to growth.

ONC Stock Gains As BeOne Medicines Wins US Nod For BEQALZI In Rare Lymphoma

The FDA approved BEQALZI in the treatment of certain mantle cell lymphoma patients on Wednesday. 


First Trust Exchange-Traded Fund - First Trust NYSE Arca Biotechnology Index Fund

Neutral Sentiment

<ul class="summary-bullets"><li>Seigerman highlighted two recent discontinuations for the individualized mRNA candidate autogene cevumeran — jointly developed by BioNTech and Genentech — in bladder cancer and colorectal cancer.</li><li>Evercore ISI called the PFS miss “disappointing, but consistent with our reading of the earlier Phase 2 data.”</li><li>Citi pointed out that the trial design still allows a positive outcome if OS improves, “preserving a meaningful development path.”</li></ul> BioNTech shares (BNTX) closed down roughly 7% on Tuesday after the company reported that its investigational mRNA cancer immunotherapy BNT113 failed to show a statistically significant progression-free survival (PFS) benefit in a key late-stage trial, a result an analyst said reflects a broader pattern of challenges for mRNA cancer vaccines.In the Phase 2/3 AHEAD-MERIT study, BNT113—an off-the-shelf mRNA immunotherapy —was tested in combination with Merck’s drug pembrolizumab versus pembrolizumab alone as first-line treatment for certain patients with unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma.At the first analysis of the dual primary endpoints, the combination did not show a statistically significant PFS improvement, the company said on Tuesday. The independent data monitoring committee recommended that the trial continue as planned to assess overall survival, the second primary endpoint. Under the pre-specified trial design, a significant OS benefit would still constitute a positive outcome even without a PFS win.<h2 class="st-heading-2">BNTX Analyst Reactions Highlight Reduced Confidence</h2>BMO Capital Markets analyst Evan David Seigerman said that the PFS miss “adds to a growing list of recent mRNA cancer vaccine setbacks” and is likely to pressure the stock.Seigerman, who maintains a Market Perform rating and $105 price target, said the miss on progression-free survival (PFS)—the length of time patients lived without their cancer getting worse—for BNT113 plus pembrolizumab in the AHEAD-MERIT study leaves open the possibility of a later overall survival (OS) benefit, meaning patients living longer overall, but with significantly reduced confidence.He highlighted two recent discontinuations for the individualized mRNA candidate autogene cevumeran — jointly developed by BioNTech and Genentech — in bladder cancer and colorectal cancer. While an OS improvement is still possible, BMO views it as less likely given today’s miss.Evercore ISI and Citi called the PFS miss disappointing. Evercore, which rates the shares ‘Outperform’ with a $130 target, said BioNTech’s valuation is tied more closely to the outlook for its pumitamig program and rival Summit Therapeutics’ upcoming readout for its experimental drug ivonescimab in first-line metastatic non-small-cell lung cancer than to this single result.Citi kept a ‘Buy’ rating and $125 target, and pointed out that the trial design still allows a positive outcome if OS improves, “preserving a meaningful development path.”<h2 class="st-heading-2">BioNTech's Optimistic Stance</h2>BioNTech Chief Medical Officer Özlem Türeci stated on Tuesday that while the PFS result was not statistically significant, the data support continued evaluation and indicate the candidate is engaging its intended mechanism. She emphasized that immune-mediated anti-tumor effects can build over time, making the OS analysis critical for assessing durable benefit in this HPV-driven disease, for which no approved HPV-targeted therapies currently exist.Investors will now watch for OS data from AHEAD-MERIT, expected later, as the company continues to position mRNA immunotherapies as a core pillar of its oncology strategy amid the transition away from COVID-19 vaccine revenues.<h2 class="st-heading-2">How Did BNTX Retail Traders React?</h2>On Stocktwits, retail sentiment around <a class="mention" data-mention="$BNTX" data-symbol-id="BNTX" href="https://stocktwits.com/symbol/BNTX" target="_blank">BNTX stock</a> jumped from neutral to bullish territory over the past 24 hours, while message volume stayed at normal levels.A Stocktwits user opined that the stock will slip further, noting that the company’s CEO Uğur Şahin, as well as CMO Özlem Türeci, who also co-founded the company, are slated to step down by the end of the year, leaving the company without fresh leadership for a while.<stembedurl>https://stocktwits.com/IndyOne/message/666392163</stembedurl>Another user opined that the trial outcome was expected given the difficulty of treating late-stage cancer and voiced optimism for the company’s other oncology assets.<stembedurl>https://stocktwits.com/eightytwentie/message/666385168</stembedurl>BNTX stock has fallen by about 7% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/gme-rises-after-hours-as-ryan-cohen-buys-another-844-k-shares-worth-near-23-m/cZxBuMNRBYp">GME Rises After Hours As Ryan Cohen Buys Another 844K Shares Worth Near $23M</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Keenjee Nama, senior research nurse, holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell lung cancer (NSCLC) at the University College London Hospital clinical research facility, Picture date: August 20, 2024. (Photo by Aaron Chown/PA Images via Getty Images)

BMO Capital Markets analyst Evan David Seigerman said that the PFS miss for BNT113 “adds to a growing list of recent mRNA cancer vaccine setbacks” and is likely to pressure the stock. 

BioNTech SE - ADR

First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund

iShares Biotechnology ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$280.30
Prev Close	$279.50
Open	$279.12
Dividend Yield	N/A
50-Day Moving Average	$268.86
Beta	N/A
Avg. Volume	74,524.05
PE Ratio	N/A

52-Week High	$281.10
52-Week Low	$188.09
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

FBT Fundamentals